MOG Antibody-Induced CNS Demyelination: from Specificity to Function

A11

IgG antibodies (Abs) specific for central nervous system (CNS) antigens such as myelin oligoden-drocytes glycoprotein (MOG) are considered crucial effector molecules in some patients with mul-tiple sclerosis (MS) and related diseases. In the proposed project, we will characterize structural requirements for immune recognition of human MOG and determine IgG-Fc biophysical profiles and effector functions linked to in vivo pathogenicity of human MOG-Abs. In detail, these are our reseach questions:

    1. Do patients with circulating MOG-specific B cells particularly benefit from B cell depletion therapy?
    2. What are the structural requirements for immune recognition of human MOG?
    3. What are the Fc biophysical profiles and effector functions of human MOG-Abs?
    4. How do human MOG-Abs act pathogenetic in vivo?


Meyer et al. J. Immunol. 2013
Principal Investigators:

Prof. Dr. med. Edgard Meinl
Institut für Klinische Neuroimmunologie
LMU München
edgar.meinl@med.uni-muenchen.de

Univ.-Prof. Dr. med. Jan Lünemann
Klinik für Neurologie mit Institut für Translationale Neurologie
Münster
jan.luenemann@ukmuenster.de

News

Thu, 28/01/2021
BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Science
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced the publication of preclinical data on its novel mRNA vaccine approach against autoimmune diseases in the peer-reviewed journal Science. The publication titled “A non-inflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis” co-authored by SFB principal investigator Ari Waisman summarizes the findings on the disease-suppressing effects […]...more
Wed, 20/01/2021
A new study on neurological manifestations of severe COVID-19 reveals nervous system immune deficiency
Patients suffering from COVID-19 can develop concomitant and long-term symptoms in their nervous system. The most common symptom in this context is the loss of the sense of smell and taste, while more severe symptoms such as stroke, cerebral seizures, or meningitis are possible. A team of scientists from the medical faculties at the Universities […]...more
Fri, 15/01/2021
Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity
It has long been acknowledged that multiple sclerosis disease risk is associated with reduced sun-exposure, and subsequent low vitamin D levels. The study by Ostkamp et al. now assessed the relationship between measures of sun exposure and MS severity. For this, the researchers analyzed data of around 2,000 patients from the German NationMS- and the […]...more